Literature DB >> 8227362

Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.

G J Johnson1, L A Leis, P C Dunlop.   

Abstract

Human platelet thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors are linked to phosphoinositide-specific phospholipase C (PI-PLC) via a G protein tentatively identified as a member of the Gq class. In contrast, platelet thrombin receptors appear to activate PI-PLC via other unidentified G proteins. Platelets from most dogs are TXA2 insensitive (TXA2-); i.e., they do not aggregate irreversibly or secrete although they bind TXA2, but they respond normally to thrombin. In contrast, a minority of dogs have TXA2-sensitive (TXA2+) platelets that are responsive to TXA2. To determine the mechanism responsible for TXA2- platelets, we evaluated receptor activation of PI-PLC. Equilibrium binding of TXA2/PGH2 receptor agonists, [125I]BOP and [3H]U46619, and antagonist, [3H]SQ29,548, revealed comparable high-affinity binding to TXA2-, TXA2+, and human platelets. U46619-induced PI-PLC activation was impaired in TXA2- platelets as evidenced by reduced (a) phosphorylation of the 47-kD substrate of protein kinase C, (b) phosphatidic acid (PA) formation, (c) rise in cytosolic calcium concentration, and (d) inositol 1,4,5 trisphosphate (IP3) formation, while thrombin-induced PI-PLC activation was not impaired. GTPase activity stimulated by U46619, but not by thrombin, was markedly reduced in TXA2- platelets. Antisera to Gq class alpha subunits abolished U46619-induced GTPase activity in TXA2-, TXA2+, and human platelets. Direct G protein stimulation by GTP gamma S yielded significantly less PA and IP3 in TXA2- platelets. Immunotransfer blotting revealed comparable quantities of Gq class alpha-subunits in all three platelet types. Thus, TXA2- dog platelets have impaired PI-PLC activation in response to TXA2/PGH2 receptor agonists secondary to G protein dysfunction, presumably involving a member of the Gq class.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8227362      PMCID: PMC288432          DOI: 10.1172/JCI116855

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  60 in total

1.  Stimulation of phospholipase C by guanine-nucleotide-binding protein beta gamma subunits.

Authors:  M Camps; C Hou; D Sidiropoulos; J B Stock; K H Jakobs; P Gierschik
Journal:  Eur J Biochem       Date:  1992-06-15

2.  Thrombin, unlike vasopressin, appears to stimulate two distinct guanine nucleotide regulatory proteins in human platelets.

Authors:  M D Houslay; D Bojanic; D Gawler; S O'Hagan; A Wilson
Journal:  Biochem J       Date:  1986-08-15       Impact factor: 3.857

3.  Inositol 1,4,5-triphosphate-induced granule secretion in platelets. Evidence that the activation of phospholipase C mediated by platelet thromboxane receptors involves a guanine nucleotide binding protein-dependent mechanism distinct from that of thrombin.

Authors:  L F Brass; C C Shaller; E J Belmonte
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

4.  Regulation of the phosphoinositide hydrolysis pathway in thrombin-stimulated platelets by a pertussis toxin-sensitive guanine nucleotide-binding protein. Evaluation of its contribution to platelet activation and comparisons with the adenylate cyclase inhibitory protein, Gi.

Authors:  L F Brass; M Laposata; H S Banga; S E Rittenhouse
Journal:  J Biol Chem       Date:  1986-12-25       Impact factor: 5.157

5.  Dihydropyridine agonist Bay K 8644 inhibits platelet activation by competitive antagonism of thromboxane A2-prostaglandin H2 receptor.

Authors:  G J Johnson; P C Dunlop; L A Leis; A H From
Journal:  Circ Res       Date:  1988-03       Impact factor: 17.367

6.  Characterization of [5,6-3H]SQ 29,548 as a high affinity radioligand, binding to thromboxane A2/prostaglandin H2-receptors in human platelets.

Authors:  A Hedberg; S E Hall; M L Ogletree; D N Harris; E C Liu
Journal:  J Pharmacol Exp Ther       Date:  1988-06       Impact factor: 4.030

7.  Purification and characterization of membrane-bound phospholipase C specific for phosphoinositides from human platelets.

Authors:  Y Banno; Y Yada; Y Nozawa
Journal:  J Biol Chem       Date:  1988-08-15       Impact factor: 5.157

8.  Receptor-mediated effects of a PGH2 analogue (U 46619) on human platelets.

Authors:  T A Morinelli; S Niewiarowski; J L Daniel; J B Smith
Journal:  Am J Physiol       Date:  1987-11

9.  Hemorrhagic thrombocytopathy with platelet thromboxane A2 receptor abnormality: defective signal transduction with normal binding activity.

Authors:  F Ushikubi; M Okuma; K Kanaji; T Sugiyama; T Ogorochi; S Narumiya; H Uchino
Journal:  Thromb Haemost       Date:  1987-04-07       Impact factor: 5.249

10.  Further studies on the specificity of diacylglycerol for protein kinase C activation.

Authors:  M Go; K Sekiguchi; H Nomura; U Kikkawa; Y Nishizuka
Journal:  Biochem Biophys Res Commun       Date:  1987-04-29       Impact factor: 3.575

View more
  6 in total

1.  Specificity of G alpha q and G alpha 11 gene expression in platelets and erythrocytes. Expressions of cellular differentiation and species differences.

Authors:  G J Johnson; L A Leis; P C Dunlop
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

2.  Platelet signal transduction defect with Galpha subunit dysfunction and diminished Galphaq in a patient with abnormal platelet responses.

Authors:  J Gabbeta; X Yang; M A Kowalska; L Sun; N Dhanasekaran; A K Rao
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

3.  Cyclooxygenase expression and platelet function in healthy dogs receiving low-dose aspirin.

Authors:  A Dudley; J Thomason; S Fritz; J Grady; J Stokes; R Wills; L Pinchuk; A Mackin; K Lunsford
Journal:  J Vet Intern Med       Date:  2012-12-26       Impact factor: 3.333

4.  Effect of adenosine A2 receptor stimulation on platelet activation-aggregation: differences between canine and human models.

Authors:  Matthew D Linden; Marc R Barnard; A L Frelinger; Alan D Michelson; Karin Przyklenk
Journal:  Thromb Res       Date:  2007-08-28       Impact factor: 3.944

5.  Effects of anticoagulant on pH, ionized calcium concentration, and agonist-induced platelet aggregation in canine platelet-rich plasma.

Authors:  Mary Beth Callan; Frances S Shofer; James L Catalfamo
Journal:  Am J Vet Res       Date:  2009-04       Impact factor: 1.156

6.  The Effects of Cyclosporine and Aspirin on Platelet Function in Normal Dogs.

Authors:  J Thomason; T Archer; R Wills; S Press; A Mackin
Journal:  J Vet Intern Med       Date:  2016-05-07       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.